Valerie Bradley

Valerie Bradley


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2024 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MKMary B. Kleinman
Mary B. Kleinman
MAMorgan S. Anvari
Morgan S. Anvari
JFJulia W. Felton
Julia W. Felton
VBValerie Bradley
Valerie Bradley
ABAnnabelle M. Belcher
Annabelle M. Belcher
JMJessica F. Magidson
Jessica F. Magidson

20 October 2023 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MKMary B. Kleinman
Mary B. Kleinman
AHAbigail C. Hines
Abigail C. Hines
MAMorgan S. Anvari
Morgan S. Anvari
VBValerie Bradley
Valerie Bradley
ASAlia Shields
Alia Shields
JMJessica F. Magidson
Jessica F. Magidson

MAMorgan S. Anvari
Morgan S. Anvari
MKMary B. Kleinman
Mary B. Kleinman
DDDwayne Dean
Dwayne Dean
ARAlexandra L. Rose
Alexandra L. Rose
VBValerie Bradley
Valerie Bradley
Jessica MagidsonJessica Magidson
Jessica Magidson
Background: The peer recovery specialist (PRS) workforce has rapidly expanded to increase access to substance-use disorder services for underserved communities. PRSs are not typically trained in evidence-based interventions (EBIs) outside of motivational interviewing, although evidence demonstrates the feasibility of PRS delivery of certain EBIs, such as a brief behavioral intervention, behavioral activation. However, characteristics that predict PRS competency in delivering EBIs such as behavioral activation remain unknown, and are critical for PRS selection, training, and supervision if the PRS role is expanded. This study aimed to explore the outcomes of a brief PRS training period in behavioral activation and identify predictors of competence. Method: Twenty PRSs in the United States completed a two-hour training on PRS-delivered behavioral activation. Participants completed baseline and post-training assessments, including roleplay and assessments of PRS characteristics, attitudes towards EBIs, and theoretically relevant personality constructs. Roleplays were coded for competence (behavioral activation specific and PRS skills more broadly, i.e., PRS competence) and changes were assessed from baseline to post-training. Linear regression models tested factors predicting post-training competence, controlling for baseline competence. Results: There was a significant pre-post increase in behavioral activation competence (t = −7.02, p < 0.001). Years working as a PRS significantly predicted post-training behavioral activation skills (B = 0.16, p = 0.005). No variables predicted post-training PRS competence. Conclusions: This study provides preliminary evidence that behavioral activation may be appropriate for dissemination to PRSs through brief trainings, particularly for PRSs with more work experience. However, additional research is needed to examine predictors of competence among PRSs.

18 August 2022 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
JBJennifer M. Belus
Jennifer M. Belus
AHAlastair van Heerden
Alastair van Heerden
HRHeidi van Rooyen
Heidi van Rooyen
VBValerie Bradley
Valerie Bradley
JMJessica F. Magidson
Jessica F. Magidson
RBRuanne V. Barnabas
Ruanne V. Barnabas
South Africa currently has the greatest number of people with HIV globally. The country has not yet met its 95-95-95 goals, with different gaps in the HIV care cascade for women and men. This paper reports on a protocol to pilot test a couple-based intervention designed to improve women's antiretroviral therapy (ART) adherence and men's engagement in care in heterosexual couples living in the Vulindlela area of KwaZulu-Natal, South Africa. Study goals are two-fold: (1) assess the acceptability, feasibility, and fidelity of the experimental intervention, START Together, and (2) collect efficacy data on START Together for women's ART adherence, men's engagement in HIV care, and the couple's relationship functioning. Women (N = 20) who were not engaged with ART adherence (defined via self-reported ART difficulties, record of missed clinic visits, or viral non-suppression) are the target patients; male partners are not required to know or disclose their HIV status to be part of the study. Couples are randomized 1:1 to the experimental treatment (START Together) or treatment as usual (referrals to the local clinic to support ART adherence or any other HIV-related care). START Together is a 5-session intervention based in cognitive-behavioral couple therapy, which is a skill-based intervention focusing on communication and problem-solving skills, and Life Steps, a problem-solving intervention identifying barriers and solutions to medication adherence. Couples are assessed at baseline, post-treatment (8 weeks post-randomization), and follow-up (12 weeks post-randomization). This study will provide preliminary implementation and efficacy data on whether this novel approach has potential to improve women and men's HIV and healthcare-related needs.

20 March 2025 in Journal of Substance Use and Addiction Treatment
Verified
Journal Article
Open access
VBValerie Bradley
Valerie Bradley
MKMary B. Kleinman
Mary B. Kleinman
MAMorgan S. Anvari
Morgan S. Anvari
TATolulope M. Abidogun
Tolulope M. Abidogun
CSC.J. Seitz-Brown
C.J. Seitz-Brown
JMJessica F. Magidson
Jessica F. Magidson
Successful outcomes in substance use disorder (SUD) treatment are traditionally defined by retention in care, substance use cessation, and relapse prevention. However, these metrics may overlook important, person-centered aspects of success, especially for marginalized populations facing significant inequities in care. With overdose-related deaths disproportionately affecting racially minoritized groups, understanding a more inclusive definition of success in opioid use disorder (OUD) treatment is essential for improving clinical treatment, research, and policy. This study explores how patients and staff define successful treatment outcomes and how those definitions align or differ at an outpatient methadone treatment program in Baltimore City. We conducted qualitative interviews and focus groups with 32 participants, including patients, clinical staff, and peer recovery specialists (PRSs) at a methadone treatment program serving primarily low-income, racially minoritized individuals with OUD. The sample was 59 % male, average age 48.7, and 66 % Black or African American. Semi-structured interview guides prompted patients (n = 20) and clinical staff/PRSs (n = 12) to describe successful treatment experiences. Data were analyzed using thematic analysis and contextualized within the Health Equity Implementation Framework to propose influences on equitable methadone treatment that optimize treatment outcomes. Five key themes emerged in defining person-centered successful treatment outcomes: (1) improvements in general health, (2) productivity and accomplishment, (3) social improvements, (4) substance use changes, and (5) treatment engagement. Patients and staff agreed on two-thirds of subthemes but showed notable differences. Patients emphasized experiential and social aspects of recovery, such as increased activities, supporting others, and resisting substance use influences. Staff focused on sustained behavioral change and long-term recovery milestones, including substance use behaviors, self-worth, community involvement, and treatment planning. Person-centered definitions of success in methadone treatment encompass a range of psychosocial, behavioral, and health-related factors. While patients and staff agreed on overall themes, their perspectives diverged on several subthemes. Incorporating diverse patient perspectives in defining methadone treatment success, particularly from marginalized groups, is essential for improving research, policy, and clinical practices to enhance patient experiences and outcomes in methadone treatment.

15 May 2026 in Addictive Behaviors Reports
Verified
Journal Article
Open access
MAMorgan S. Anvari
Morgan S. Anvari
CSCaroline A. Sacko
Caroline A. Sacko
NTNoah Triplett
Noah Triplett
VBValerie Bradley
Valerie Bradley
MKMary B. Kleinman
Mary B. Kleinman
JMJessica F. Magidson
Jessica F. Magidson
Stigma is a well-recognized barrier to substance use (SU) treatment initiation and retention. It is theorized to operate through three distinct mechanisms: internalized, enacted, and anticipated. The unique associations between these specific stigma mechanisms and key psychosocial factors – such as engagement in reinforcing activities (i.e., behavioral activation), depression, and SU-related problems (e.g., social, financial) – remain unexplored, particularly among historically underserved populations. The current study examined how SU stigma in total and each mechanism is associated with these outcomes among individuals in an urban methadone clinic serving a historically underserved community. This cross-sectional study utilized baseline data from a peer-delivered behavioral intervention trial to examine how SU stigma mechanisms are associated with behavioral activation (BA), depressive symptoms, and SU-related problems among a predominantly low-income sample in methadone treatment (N = 212). Linear regression analyses revealed that overall SU stigma was associated with lower BA, higher depressive symptoms, and greater SU-related problems. In multiple linear regression models controlling for relevant covariates and stigma mechanisms, higher internalized SU stigma remained significantly associated with worse outcomes across all domains. Following multiple-testing correction, associations for anticipated stigma (with lower BA and higher depressive symptoms) and enacted stigma (with greater SU-related problems) were marginally significant. Findings highlight differential associations of stigma mechanisms in psychosocial functioning, and may point to a need to address internalized stigma in SU interventions. Future longitudinal research is needed to assess causal and mechanistic relationships between stigma, SU and psychosocial outcomes to inform targeted intervention development.